Recent experiments have investigated the possible mechanism of antioxidant-based therapeutics in AD and their free-radical-scavenging activity based on increasing antioxidant enzymes from the Nrf2/HO-1 pathway and have shown that the removal of hydrogen peroxide inhibits amyloid accumulation [35]. The gene discussed is NFE2L2; the disease is Alzheimer disease.